Abstract: The Carney triad is the combination of gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma. Herein, we describe the clinical, imaging, pathologic, and follow-up findings from 14 patients for a fourth component of the syndrome, adrenal adenoma. The adrenal neoplasm was asymptomatic and usually a late finding. Results of adrenocortical function tests were normal. Computed tomography revealed lowdensity adrenal masses that were consistent with adenomas. Bilateral lesions were present in 4 patients. In 13 of the 14 patients who underwent surgery, resected adrenal glands and biopsy specimens featured 1 or more circumscribed, yellow tumors, up to 3.5 cm in diameter, composed of well-differentiated polygonal cells with clear vacuolated cytoplasm and a smaller component of eosinophilic cells. The extratumoral cortex had combinations of normal histologic features, discrete clear cell micronodules, zonal clear cell hypertrophy, and marked atrophy. The lesion in the 14th patient was different, grossly and microscopically resembling the usual sporadic cortisol-secreting adenoma. After the tumor was excised, the patient required glucocorticoid support. None of the tumors recurred or metastasized. Fourteen additional patients had unilateral or bilateral adrenal tumors consistent with adenomas detected by imaging studies.
T he Carney triad (CTr) was described in 1977 as "the triad of gastric leiomyosarcoma, functioning extraadrenal paraganglioma, and pulmonary chondroma." 1 The syndrome was found in 7 unrelated young women.
One, aged 16 years, had a 5 mm adrenocortical adenoma. Later, when adenomas were found in several other patients with the syndrome, it was evident that adrenocortical adenoma was a fourth component of CTr. 2 The 3 tumors in the initial description of the syndrome were multicentric and multifocal; they affected young patients, suggesting a genetic cause. The gene for CTr remains elusive, but genomic changes have been found. 3 The gastric tumors, the most common component of the disorder, originate in the interstitial cells of Cajal 4 and have been extensively studied. 5, 6 They usually occur in the gastric antrum and metastasize to the liver and lymph nodes. They differ clinically, pathologically, and behaviorally from sporadic, nonsyndromic gastrointestinal stromal tumors. 6 The pulmonary chondromas are benign lesions composed solely of cartilage. 7 The neoplasm may be single or multiple and unilateral or bilateral. It is often misinterpreted pathologically as pulmonary hamartoma, but it lacks bronchial epithelium, an essential component of pulmonary hamartoma. 8 The paraganglionic component, the least frequent of the 3 major components, may occur anywhere in the paraganglionic system, including unusual locations such as the aortopulmonary body and the heart, and may be malignant. 2 This article presents the clinical, imaging, pathologic, behavioral, and follow-up findings from 28 patients who had CTr: 14 had 1 or more proven adrenocortical adenomas, and 14 had an adrenal tumor, consistent with cortical adenoma, that was detected by imaging. In 13 of the 14 who underwent adrenal surgery, the resected adrenal neoplasms were unilateral or bilateral, multifocal, and composed of clear vacuolated cells with a variable population of eosinophilic cells. The extratumoral cortex had clear cell micronodules and other abnormalities. The pathologic findings in the 14th patient (who, in retrospect, had subclinical Cushing syndrome) resembled those of a sporadic cortisol-secreting adenoma. None of the tumors in the 14 operated patients recurred or metastasized.
PATIENTS AND METHODS
In coauthor J.A.C.'s database of 149 patients with CTr, 28 (19%) had 1 or more proven or suspected adrenocortical tumors. The presence of 2 of the 3 major component tumors multifocally was accepted as sufficient for diagnosis of the syndrome. Of the 28 patients (27 female, 1 male), 11 were evaluated at Mayo Clinic (Rochester, MN), 1 was evaluated at the National Institutes of Health (Bethesda, MD), 10 were described in publications, 9-17 and 6 were communicated to J.A.C. Patient records and publications were reviewed for: adrenal symptomatology; results of abdominal imaging, iodine-131 metaiodobenzylguanidine ( 131 I-MIBG) scintigraphy, and adrenocortical function testing; treatment of the adrenal neoplasm; and follow-up. Two patients (patients 2 and 8) had paraganglioma (pheochromocytoma) in addition to a cortical tumor in the resected gland. In 24 patients the lesions were discovered by imaging; in 4 patients, the lesions were found at surgery.
The resected adrenal glands and adrenal excisional biopsy specimens were fixed in formalin and embedded in paraffin. Hematoxylin and eosin (H&E)-stained slides were available for 13 patients, and 1 or more formalinfixed, paraffin-embedded blocks were obtained for 9 of the 13. Sections of 4 mm thickness were used for H&E staining, histochemical analysis (periodic acid-Schiff, reticulin, and Masson trichrome stains), and immunocytochemical analysis. The thickness of the extratumoral cortex was measured in H&E-stained sections at Â 100 magnification with a 1 cm intraocular scale divided into 100 units. Table 1 presents the CTr components in the 28 patients, the age at diagnosis of the first lesion (mean, 22 y), and the age at detection of proven (mean, 32 y) or imaged (mean, 37 y) adrenal cortical tumors. No patient had adrenal symptoms preoperatively, and results of limited laboratory testing of adrenocortical function were normal (patient 28 had complete testing). Four patients had normal levels of plasma cortisol, and 2 others had normal results from dexamethasone suppression testing. One patient had elevated levels of plasma cortisol before and after adrenalectomy; they were interpreted as resulting from estrogen therapy. 11 Patient 1 had normal 24-hour urinary-free cortisol levels 4 years before adrenalectomy, but adrenal insufficiency (confirmed by laboratory testing) developed after adrenalectomy; cortical function normalized in 3 months. Four patients had bilateral lesions that were pathologically proven (1 patient), pathologically proven and contralaterally imaged (1 patient) or bilaterally imaged (2 patients).
RESULTS
Imaging results, tumor treatment, and follow-up information for the 28 patients are shown in Table 2 . Computed tomographic images were compatible with a low-density or lipid-rich lesion, suggestive of a benign adenoma. Results of 131 I-MIBG scintigraphy were negative for 11 patients.
The rate of growth of the adrenal tumors was unpredictable. Patient 6 had normal adrenal imaging 
Pathology Gross
The resected adrenal glands and excisional biopsy specimens from 13 patients featured 1 to 6 circumscribed, solid, yellow tumors, 4 mm to 3.5 cm in diameter (Fig. 1A) . Close to twenty 1 to 2 mm yellow lesions were attached to the adrenal capsule of 1 tumor (Fig. 1A) . The extratumoral cortex usually appeared normal with an outer yellow layer and an inner brown layer (Fig. 1A) .
The findings in the remaining patient were different (Fig. 1C ). There were 2 juxtaposed tumors: 1 was tan with red, brown, black, and yellow; the other was dark tan with radiating dark red zones. The attached cortex was thin and yellow.
Light Microscopy
The tumors were limited by a thin adrenal capsule, or an incomplete fibrous pseudocapsule, or they were circumscribed and in direct contact with the stretched or compressed cortex. There were areas of scarring in some of the neoplasms.
On H&E staining, the tumors were found to have 2 types of cells. Most were polygonal, medium-sized, and well-outlined with clear vacuolated cytoplasm (Fig. 2) . They were arranged in tightly packed clusters that formed broad sheets, some of which appeared vaguely lobulated. Occasional cells were ballooned, and some smaller ones had a tinge of cytoplasmic eosinophilia. A minority of the 
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Adrenal Cortical Adenoma in Carney Triad cells were small and poorly outlined, and they had eosinophilic cytoplasm ( Fig. 2A) . These cells were randomly disposed in zones of various sizes and shapes and in narrow ramifying bands among the clear cells. The degree of eosinophilia ranged from weak to very strong; the cytoplasm varied from fine granular to homogenous. The 2 cell types were separate with minimal transition between them. In patient 1, the eosinophilic cells were arranged in large, irregularly shaped zones or round nodules (Fig. 3A) . Some cells were large or huge (Fig. 3B) ; a few had lipochrome (Fig. 3C) . The nuclei were small, round, and centrally located, with dense darkly staining chromatin and 1 or 2 very small nucleoli. They were uniformly distributed in the cells and occasionally tightly stacked in some of the eosinophilic cells. Scattered larger cells had correspondingly enlarged nuclei (Fig. 2B ). Multinucleation was rare. There was nuclear atypia (nucleomegaly, hyperchromatism, and intranuclear vacuoles) in the eosinophilic cells in patient 1 (Fig. 3D ). Mitoses were not seen.
The stroma was inconspicuous. Some tumors had fine arborizing or stellate scarring, and there were some dilated, occasionally hyalinized, blood vessels.
The extratumoral cortex adjacent to but not surrounding the tumor showed combinations of normal histology features (Fig. 1B) , segmental atrophy (Fig. 1D) , discrete clear cell micronodules (Fig. 4A) , zonal clear cell hypertrophy (Fig. 4A) , and cortical extrusions (Figs. 1A,  4B) . Micronodules, present in 5 of 8 patients, were defined as roughly spherical, unencapsulated areas of hypertrophied cortical clear cells, usually <1 mm but up to 2 mm in diameter. There was sufficient extratumoral cortex available in 7 specimens for thickness measurements: 0.43 mm (28 measurements) to 0.91 mm (16 measurements) in 4 glands; 0.96 mm (33 measurements) in the specimen in Figure 1B ; and 1.46 mm in 1 section (15 measurements) and 0.55 mm in a second section (4 measurements) in the remaining cortex. The thickness of the normal adult cortex is 0.7 to 1.3 mm. 18 The extratumoral capsule was intact except where it was penetrated by cortical extrusions in 2 patients (Figs. 1A,  4B) . A focus of ovarian thecal metaplasia extended from the capsule into the cortex in 3 of the female patients.
Immunostaining
The immunostaining results showed variability in the degree of staining (strong, weak, or equivocal), the site of cell staining (cytoplasm or cell membrane), the type of staining (single large cytoplasmic body, coarse granularity, or fine granularity); and inconsistency (adjacent histologically similar cells stained or did not stain). Differences in tissue processing and age of sections may have been contributing factors. Moreover, the functional state and the particular presumptive steroid products of the tumor cells may have differed among the tumors. Only consistent results are presented (Fig. 5) . Results for the 
DISCUSSION
This study describes the clinical, imaging, pathologic, and behavioral features of 28 proven or suspected adrenocortical adenomas from 28 patients with CTr. The tumors were asymptomatic and were discovered incidentally during imaging studies or at surgery for gastric stromal sarcoma. They occurred almost exclusively in women (96%) and were detected through a wide age range (16 to 68 y); sometimes a long interval (up to 58 y) separated detection of the first CTr tumor and discovery of the adrenal lesion, which was generally the last component of the syndrome to be detected.
The adrenal neoplasm was single or multiple, unilateral or bilateral, circumscribed, small to intermediate in size, and almost always yellow. Microscopically, it was well delineated and composed of moderately sized cells with clear vacuolated cytoplasm (resembling cells of the normal adrenal zona fasciculata) and a variably sized component of eosinophilic cells (resembling those of the normal zona reticularis). Clear cell micronodules (microscopically similar to the tumors) were present in the extratumoral cortex, which elsewhere was normal, segmentally hyperplastic, or atrophic.
Clear cell micronodules are a common finding at autopsy in older individuals and are not considered neoplastic or preneoplastic. 19 However, as they occurred in 5 of 8 patients in the present study, they were most likely part of the adrenal pathologic features of CTr, particularly because they were multiple and morphologically similar to the clear cells in the cortical adenomas. Clear cell micronodules probably remain in patients who had partial adrenalectomy and in the contralateral gland of the patients who had unilateral adrenalectomy; new adenomas might develop from these micronodules. The findings from patient 1 deserve comment because they were different clinically and pathologically from the others. The patient's 2 adenomas were similar to the usual sporadic cortisol-secreting adrenal adenoma. Intraoperative pathologic examination of the resected gland revealed marked atrophy of the extratumoral cortex, as is found with a cortisol-producing adenoma. This suggested that the patient's neoplasm had been producing excessive amounts of cortisol that had affected corticotropin secretion. If this was true, the cortex in the patient's remaining adrenal gland was likely atrophic as well, and a postoperative Addisonian crisis could occur. As a precautionary measure, corticosteroid was administered intraoperatively. After adrenalectomy, there was a 3-month period of gradually improving adrenocortical function (confirmed by laboratory assessment) during which the patient needed glucocorticoid replacement.
The pathologic and clinical evolutionary features noted in this patient are consistent with the patient having had subclinical Cushing syndrome preoperatively. The probability seems remote that a sporadic cortisol-secreting adenoma, itself an uncommon tumor, occurred by chance in a patient with CTr, which is a very rare disorder. Therefore, it must be anticipated that glucocorticoid secretory autonomy may develop in exceptional patients who have CTr. Interestingly, the histology of this patient's atrophic cortex (small eosinophilic cells) was different from that found with sporadic cortisol-secreting adrenal adenoma (ballooned clear lipid-filled cells). The severe focal cortical atrophy in 2 other patients may have been a normal phenomenon. 20 The long-term follow-up data after resection of the adrenal tumors (mean follow-up, 13 y) gave good insight into their natural history. None recurred locally or metastasized, providing convincing evidence that the tumors were benign and giving reassurance that the unresected adrenal tumors (thought to be adenomas by imaging) for the 14 patients who did not undergo surgery were also benign. Average follow-up in these patients was 9 years. These findings suggest that the adrenal adenomas in CTr should be managed conservatively. The adrenal glands may be examined during follow-up computed tomography monitoring of the gastric tumor. If resection of an apparently nonfunctioning adrenal adenoma is planned, subclinical Cushing syndrome should be ruled out and 131 I-MIBG scintigraphy (to rule out pheochromocytoma) should be performed.
Our adrenal findings in CTr patients are different clinically and pathologically from those in patients with several genetic syndromes: Carney complex features primary pigmented nodular adrenocortical disease 21 ; McCune-Albright syndrome displays bimorphic adrenocortical disease 22 ; and Beckwith-Wiedemann syndrome manifests with cytomegaly and fetal cortical abnormality. 19 The findings described herein add another entity to this group of disorders. Multiple bilateral cortical tumors also occur in other conditions, including corticotropinindependent macronodular hyperplasia, which features multiple yellow clear and compact cell adenomas in a hyperplastic cortex, 23 and multiple endocrine neoplasia 1 (MEN1), which features bilateral, hyperplastic, and usually nonfunctional lesions. 24 In summary, we have described the clinical, pathologic, and behavioral features of the adrenocortical tumor that is the fourth component of CTr. Clinically, the tumor was asymptomatic, and behaviorally it was benign. The pathologic features included multifocal and multicentric clear cell adenomas and extratumoral clear cell micronodules. One patient had cortisol-producing tumors and subclinical Cushing syndrome. The pathologic findings are an addition to the group of genetically mediated bilateral adrenocortical tumors.
